United
States
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
April
13, 2021
Date
of Report (Date of earliest event reported)
BCTG
Acquisition Corp.
(Exact
Name of Registrant as Specified in its Charter)
Delaware
|
|
001-39485
|
|
85-1195036
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
12860
El Camino Real, Suite 300
San
Diego, CA
|
|
92130
|
(Address of Principal Executive
Offices)
|
|
(Zip Code)
|
Registrant’s
telephone number, including area code: (858) 400-3120
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☒
|
Written communications
pursuant to Rule 425 under the Securities Act
|
☐
|
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act
|
☐
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act
|
☐
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which
registered
|
Common Stock
|
|
BCTG
|
|
The Nadsaq Stock Market
LLC
|
Item
1.01. Entry Into a Material Definitive Agreement
On
April 13, 2021, BCTG Acquisition Corp., a Delaware corporation (“BCTG”), entered into an agreement and plan of merger (as
it may be amended and/or restated from time to time, the “Merger Agreement”), by and among BCTG, BCTG Merger Sub Inc., a
Delaware corporation and a wholly-owned subsidiary of BCTG (“Merger Sub”), and Tango Therapeutics, Inc. (“Tango”).
The
Merger Agreement was unanimously approved by all of BCTG’s directors on April 13, 2021. Pursuant to the Merger Agreement, at the
closing of the transactions contemplated thereby, Merger Sub will merge with and into Tango (the “Merger”) with Tango surviving
the merger as a wholly-owned subsidiary of BCTG (the “Business Combination”). In addition, in connection with the consummation
of the Business Combination, BCTG will be renamed “Tango Therapeutics, Inc.”
Consideration
Under
the Merger Agreement, BCTG has agreed to acquire all of the outstanding shares of Tango common stock (including any options or warrants
exercisable therefor) for $550,000,000 in aggregate consideration, comprising 55,000,000 shares of BCTG common stock, based on a price
of $10.00 per share (such shares being referred to herein as the “Merger Consideration”).
At
the effective time of the Merger (the “Effective Time”), by virtue of the Merger and without any further action on the part
of BCTG, Merger Sub or Tango (after Tango causes each share of Tango preferred stock that is issued and outstanding immediately prior
to the consummation of the Business Combination to be automatically converted immediately prior to the consummation of the Business Combination
into a number of shares of Tango common stock at the then-effective conversation rate as calculated in accordance with Tango’s
organizational documents), each share of Tango common stock issued and outstanding immediately prior to the Effective Time shall be canceled
and automatically converted into the right to receive a number of shares of BCTG equal in value to the quotient of the Merger Consideration
divided by the fully diluted capitalization of Tango (the “Exchange Ratio”) without interest. Each outstanding Tango option
shall be assumed by BCTG and automatically converted into an option to purchase such number of shares of BCTG’s common stock, as
adjusted based on the Exchange Ratio. If any shares of Tango common stock issued and outstanding immediately prior to the Effective Time
are shares of Tango restricted stock, then the shares of BCTG common stock issued in exchange for such shares of Tango restricted stock
shall to the same extent be unvested and subject to the same repurchase option or risk of forfeiture as in effect immediately prior to
the Effective Time, and the certificates and/or book entries representing such shares of BCTG common stock shall accordingly be marked
with appropriate legends. No certificates or scrip representing fractional shares of BCTG’s common stock will be issued pursuant
to the Merger. Stock certificates evidencing the Merger Consideration shall bear restrictive legends as required by any securities laws
at the time of the Merger.
BCTG
Post-Closing Board of Directors and Executive Officers
Immediately
following the closing, BCTG’s board of directors will consist of nine directors, consisting of Barbara Weber, Reid Huber, Alexis
Borisy, Malte Peters, Aaron Davis, Mace Rothenberg and Lesley Calhoun. At the closing, all of the executive officers of BCTG shall resign
and the individuals serving as executive officers of BCTG immediately after the closing will be the same individuals (in the same offices)
as those of Tango immediately prior to the closing.
Stockholder
Approval
BCTG
will prepare and file with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-4, that
will include a preliminary proxy statement/prospectus, and when available, a definitive proxy statement and final prospectus (the “Proxy
Statement”), and call a special meeting of its holders of BCTG common stock to vote at the meeting (the “Special Meeting”).
The holders of the majority of the voting power of BCTG’s common stock present in person or represented by proxy at the Special
Meeting of BCTG’s stockholders must approve the Merger Agreement, the Business Combination and certain other actions related thereto
as provided in the Delaware General Corporation Law, BCTG’s certificate of incorporation and applicable listing rules of The Nasdaq
Stock Market LLC.
Representations
and Warranties; Covenants
BCTG,
Merger Sub and Tango have made customary representations, warranties and covenants in the Merger Agreement, including, among other things,
covenants with respect to the conduct of BCTG and Tango prior to the closing of the Business Combination. The parties have also agreed
to customary “no shop” obligations. The representations and warranties of BCTG, Merger Sub and Tango will not survive the
closing of the Business Combination.
Closing
Conditions
The
closing of the Business Combination is subject to certain customary conditions of the respective parties, including, among other things,
that: (i) applicable stockholder approval shall have been received; (ii) there shall have been no Material Adverse Effect (as defined
in the Merger Agreement) with respect to Tango since the date of the Merger Agreement; (iii) the waiting period (or any extension thereof)
applicable under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 shall have expired or terminated; (iv) BCTG shall have at least
$5,000,001 of net tangible assets immediately following the closing (after giving effect to the redemption of public shares by BCTG’s
public stockholders); (v) BCTG shall have proceeds at the closing of the Business Combination, comprised of amounts held in trust and
amounts raised pursuant to the Subscription Agreements (as defined below), net of any amount required to satisfy the redemptions and
net of BCTG’s expenses (the “Closing Cash”) of at least $300 million (subject to the Closing Cash Shortfall provision
described below); (vi) BCTG’s initial listing application in connection with the Transactions (as defined in the Merger Agreement)
shall have been approved by The Nasdaq Capital Market (“Nasdaq”) so that immediately following the Merger, BCTG satisfies
any applicable initial and continuing listing requirements of Nasdaq; (vii) certain Tango stockholders shall have delivered a lock-up
agreement; and (viii) BCTG and certain Tango stockholders shall have entered into the BCTG Amended and Restated Registration Rights Agreement
(as defined below).
Termination
The
Merger Agreement may be terminated by BCTG or Tango under certain circumstances, including, among others; (i) by mutual written consent
of BCTG and Tango; (ii) by either BCTG or Tango if the closing of the Business Combination has not occurred on or before September 30,
2021; (iii) by BCTG or Tango if BCTG has not obtained the necessary stockholder approvals; or (iv) by BCTG if Tango has not timely delivered
written consent of the Tango stockholders to the Merger Agreement.
The
foregoing summary of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the actual
Merger Agreement, which is filed as Exhibit 2.1 hereto, and which is incorporated by reference herein.
Additional
Agreements to be Executed at the Signing of the Merger Agreement
PIPE
Subscription Agreements
BCTG
entered into subscription agreements (the “Subscription Agreements”) dated as of April 13 , 2021, with certain institutional
and accredited investors, pursuant to which, among other things, BCTG agreed to issue and sell, in a private placement to close immediately
prior to the closing of the Business Combination, an aggregate of 18,610,000 shares of BCTG common stock for $10.00 per share (the “PIPE
Shares”) for a total of $186,100,000.00.
Pursuant
to the Subscription Agreements, BCTG agreed that, within 30 calendar days after the closing of the Business Combination, BCTG will file
with the SEC (at BCTG’s sole cost and expense) a registration statement registering the resale of the PIPE Shares (the “PIPE
Resale Registration Statement”), and BCTG shall use its commercially reasonable efforts to have the PIPE Resale Registration Statement
declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the 60th calendar day after
the consummation of the Transactions (or the 90th calendar day after the consummation of the Transactions if the PIPE Resale Registration
Statement is reviewed by, and comments thereto are provided by, the SEC) following the closing of the Business Combination and (ii) the
5th business day after the date BCTG is notified (orally or in writing, whichever is earlier) by the SEC that the PIPE Resale Registration
Statement will not be “reviewed” or will not be subject to further review.
The
foregoing description of the Subscription Agreements does not purport to be complete and is qualified in its entirety by the terms and
conditions of the form of the Subscription Agreement filed as Exhibit 10.1 hereto and incorporated by reference herein.
Support
Agreements
In
connection with the Merger Agreement, certain directors and holders of equity securities of Tango each entered into a support agreement
(the “Company Support Agreement”) with BCTG and Tango, pursuant to which each such director and holder of equity securities
of Tango agrees to vote the shares of Tango capital stock beneficially owned by them in favor of each of the proposals to be included
in the applicable written consent of stockholders, to take all actions reasonably necessary to consummate the Business Combination and
to vote against any proposal that would prevent the satisfaction of the conditions to the Business Combination set forth in the Merger
Agreement. Promptly after the execution of the Merger Agreement, certain additional stockholders of Tango will enter into the Company
Support Agreement.
The
foregoing description of the Company Support Agreement is qualified in its entirety by reference to the full text of the form of Company
Support Agreement, a copy of which is included as Exhibit A to the Merger Agreement, filed as Exhibit 10.2 to this Current Report on
Form 8-K, and incorporated herein by reference.
In
connection with the execution of the Merger Agreement, BCTG Holdings, LLC, the sponsor of BCTG (the “Sponsor”) entered into
a support agreement (the “Parent Support Agreement”) with Tango and BCTG, pursuant to which BCTG Holdings, LLC agrees to
vote all shares of BCTG common stock beneficially owned by it in favor of each of the proposals to be presented at the Special Meeting,
to take all actions reasonably necessary to consummate the Business Combination and to vote against any proposal that would prevent the
satisfaction of the conditions to the Business Combination set forth in the Merger Agreement.
The
foregoing description of the Parent Support Agreement is qualified in its entirety by reference to the full text of the form of Parent
Support Agreement, a copy of which is included as Exhibit B to the Merger Agreement, filed as Exhibit 10.3 to this Current Report on
Form 8-K, and incorporated by reference herein.
Affiliate
Share Purchases
In
connection with the signing of the Merger Agreement, an affiliate of Boxer Capital, a member of the Sponsor, agreed to purchase 800,000
shares of BCTG’s common stock from two holders of public shares at a price of $11.00 per share.
Closing
Cash Shortfall
The Sponsor and Tango have agreed
that if the Closing Cash is less than $300,000,000 (such deficit, the “Shortfall”), the Sponsor shall have the option either
increasing its cash investment amount in BCTG by purchasing additional shares of BCTG common stock up to the amount of the Shortfall,
or securing investments in BCTG common stock from other investors.
Additional
Agreements to be Executed at Closing
The
Merger Agreement provides that, upon consummation of the Transactions, BCTG will enter into the following additional agreements.
BCTG
Amended and Restated Registration Rights Agreement
At
the closing, BCTG will enter into an amended and restated registration rights agreement (the “BCTG Amended and Restated Registration
Rights Agreement”) with certain existing stockholders of BCTG with respect to the shares of BCTG common stock they own at the closing,
and certain Tango stockholders of BCTG with respect to the Merger Consideration. The BCTG Amended and Restated Registration Rights Agreement
will require BCTG to, among other things, file a resale shelf registration statement on behalf of the stockholders no later than 30 days
after the closing of the Business Combination. The BCTG Amended and Restated Registration Rights Agreement will also provide certain
demand registration rights and piggyback registration rights to such stockholders, subject to underwriter cutbacks and issuer blackout
periods. BCTG will agree to pay certain fees and expenses relating to registrations under the BCTG Amended and Restated Registration
Rights Agreement.
The
foregoing description of the BCTG Amended and Restated Registration Rights Agreement is qualified in its entirety by reference to the
full text of the form of such agreement, a copy of which is included as Exhibit G to the Merger Agreement, filed as Exhibit 10.4 to this
Current Report on Form 8-K, and incorporated herein by reference.
Lock-up
Agreement
In
connection with the closing of the Business Combination, certain stockholders of Tango will enter into a lock-up agreement (the “Stockholder
Lock-Up Agreement”) with BCTG, pursuant to which each will agree, subject to certain customary exceptions, not to:
|
(i)
|
offer, sell, contract to
sell, pledge, or otherwise dispose of, directly or indirectly, any shares of BCTG common stock or securities convertible into or
exercisable or exchangeable for BCTG common stock held by it immediately after the Effective Time, or enter into a transaction that
would have the same effect;
|
|
(ii)
|
enter into any swap, hedge
or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of any of such shares, whether
any of these transactions are to be settled by delivery of such shares, in cash or otherwise; or
|
|
(iii)
|
publicly announce the intention
to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement, or engage in
any “Short Sales” (as defined in the Stockholder Lock-up Agreement) with respect to any security of BCTG;
|
until
the date that is 180 calendar days after the consummation of the Business Combination; provided, however, that the restrictions set forth
in the Lock-up Agreement shall not apply to (1) transfers or distributions to such stockholders current or former general or limited
partners, managers or members, stockholders, other equityholders or other direct or indirect affiliates (within the meaning of Rule 405
under the Securities Act of 1933, as amended) or to the estates of any of the foregoing; (2) transfers by bona fide gift to a member
of the stockholder’s immediate family or to a trust, the beneficiary of which is the stockholder or a member of the stockholder’s
immediate family for estate planning purposes; (3) by virtue of will, intestate succession or the laws of descent and distribution upon
death of the stockholder; (4) pursuant to a qualified domestic relations order, in each case where such transferee agrees to be bound
by the terms of Stockholder Lock-up Agreement; (5) establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act for
the transfer of Restricted Securities. Notwithstanding the foregoing, if after consummation of the Business Combination, there is a “Change
of Control” of BCTG (as defined in the Lock-up Agreement), all of the shares shall be released from the restrictions set forth
therein.
The
foregoing description of the Stockholder Lock-Up Agreements is qualified in its entirety by reference to the full text of the form of
Stockholder Lock-up Agreement, a copy of which is included as Exhibit D to the Merger Agreement, filed as Exhibit 10.5 to this Current
Report on Form 8-K, and incorporated herein by reference.
Item
3.02 Unregistered Sales of Equity Securities
The
disclosure set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. The PIPE Shares will
not be registered under the Securities Act of 1933, as amended (the “Securities Act”) in reliance upon the exemption provided
in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.
Item
7.01 Regulation FD Disclosure
On
April 14, 2021 Tango issued a press release announcing the execution of the Merger Agreement. Attached hereto as Exhibit 99.1 and incorporated
into this Item 7.01 by reference is the copy of the press release.
Attached
hereto as Exhibit 99.2 and incorporated into this Item 7.01 by reference is the investor presentation that will be used by BCTG in making
presentations to certain existing stockholders of BCTG and other persons with respect to the Transaction.
The
information in this Item 7.01 (including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed to be filed for purposes
of Section 18 of the Exchange Act , or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated
by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Important
Information and Where To Find It
In
connection with the proposed Business Combination described herein, BCTG intends to file relevant materials with the SEC, including a
Registration Statement on Form S-4, that includes a preliminary proxy statement/prospectus, and when available, a definitive proxy statement
and final prospectus. Promptly after filing its definitive proxy statement with the SEC, BCTG will mail the definitive proxy statement
and a proxy card to each stockholder entitled to vote at the Special Meeting relating to the transaction. INVESTORS AND STOCKHOLDERS
OF BCTG ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION
WITH THE TRANSACTION THAT BCTG WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT
BCTG, TANGO AND THE TRANSACTION. The definitive proxy statement, the preliminary proxy statement and other relevant materials in connection
with the transaction (when they become available), and any other documents filed by BCTG with the SEC, may be obtained free of charge
at the SEC’s website (www.sec.gov).
Participants
in the Solicitation
BCTG
and its directors and executive officers may be deemed participants in the solicitation of proxies from BCTG’s stockholders with
respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests
in BCTG will be included in the proxy statement for the proposed Business Combination and be available at www.sec.gov. Additional information
regarding the interests of such participants will be contained in the proxy statement for the proposed Business Combination when available.
Information about BCTG’s directors and executive officers and their ownership of BCTG common stock is set forth in BCTG’s
prospectus, dated September 2, 2020, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing.
Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement pertaining
to the proposed business combination when it becomes available. These documents can be obtained free of charge from the sources indicated
above.
Tango
and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of
BCTG in connection with the proposed Business Combination. A list of the names of such directors and executive officers and information
regarding their interests in the proposed Business Combination will be included in the proxy statement for the proposed Business Combination.
Forward-Looking
Statements
This
Current Report on Form 8-K and the documents incorporated by reference herein (this “Current Report”) contain certain “forward-looking
statements” within the meaning of “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements can be identified by words such as: “target,” “believe,” “expect,” “will,”
“shall,” “may,” “anticipate,” “estimate,” “would,” “positioned,”
“future,” “forecast,” “intend,” “plan,” “project,” “outlook”
and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Examples
of forward-looking statements include, among others, statements made in this Current Report regarding the proposed transactions contemplated
by the Merger Agreement and the Subscription Agreements, including the benefits of the Merger, integration plans, expected synergies
and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected
management and governance of the combined company, and the expected timing of the Merger. Forward-looking statements are neither historical
facts nor assurances of future performance. Instead, they are based only on BCTG’s and Tango’s managements’ current
beliefs, expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results and outcomes
may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking
statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking
statements include, among others, the following: (1) the occurrence of any event, change, or other circumstances that could give rise
to the termination of the Merger Agreement; (2) the outcome of any legal proceedings that may be instituted against BCTG and Tango following
the announcement of the Merger Agreement and the transactions contemplated therein; (3) the inability to complete the proposed Business
Combination, including due to failure to obtain approval of the stockholders of BCTG and Tango, certain regulatory approvals, or satisfy
other conditions to closing in the Merger Agreement; (4) the occurrence of any event, change, or other circumstance that could give rise
to the termination of the Merger Agreement or could otherwise cause the transaction to fail to close; (5) the failure to meet the minimum
cash requirements of the Merger Agreement due to BCTG stockholder redemptions and the failure to obtain replacement financing; (6) the
inability to complete the concurrent PIPE; (7) the failure to meet projected development and production targets; (8) the impact of COVID-19
pandemic on Tango’s business and/or the ability of the parties to complete the proposed Business Combination; (9) the inability
to obtain or maintain the listing of BCTG’s shares of common stock on Nasdaq following the proposed Business Combination; (10)
the risk that the proposed Business Combination disrupts current plans and operations as a result of the announcement and consummation
of the proposed Business Combination; (11) the ability to recognize the anticipated benefits of the proposed Business Combination, which
may be affected by, among other things, competition, the ability of Tango to grow and manage growth profitably, and retain its key employees;
(12) costs related to the proposed Business Combination; (13) changes in applicable laws or regulations; (14) the possibility that BCTG
or Tango may be adversely affected by other economic, business, and/or competitive factors; (15) risks relating to the uncertainty of
the projected financial information with respect to Tango; (16) risks related to the organic and inorganic growth of Tango’s business
and the timing of expected business milestones; (17) the amount of redemption requests made by BCTG’s stockholders; and (18) other
risks and uncertainties indicated from time to time in the final prospectus of BCTG for its initial public offering dated September 2,
2020 filed with the SEC and the Registration Statement on Form S-4, that includes a preliminary proxy statement/prospectus, and when
available, a definitive proxy statement and final prospectus relating to the proposed Business Combination, including those under “Risk
Factors” therein, and in BCTG’s other filings with the SEC. BCTG cautions that the foregoing list of factors is not exclusive.
BCTG and Tango caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.
BCTG and Tango do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking
statements to reflect any change in their expectations or any change in events, conditions, or circumstances on which any such statement
is based, whether as a result of new information, future events, or otherwise, except as may be required by applicable law. Neither Tango
nor BCTG gives any assurance that either Tango or BCTG, or the combined company, will achieve its expectations.
No
Offer or Solicitation
This
Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there
be any sale of securities in any states or jurisdictions in which such offer, solicitation, or sale would be unlawful prior to registration
or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus
meeting the requirements of Section 10 of the Securities Act, or an exemption therefrom.
Item
9.01. Financial Statements and Exhibits
Exhibit
No.
|
|
Description
|
|
|
|
2.1*
|
|
Agreement
and Plan of Merger, dated as of April 13, 2021 by and among BCTG Acquisition Corp., BCTG Merger Sub Inc. and Tango Therapeutics,
Inc.
|
10.1
|
|
Form
of Subscription Agreement, dated as of April 13, 2021 by and among BCTG Acquisition Corp. and certain institutional and accredited
investors
|
10.2
|
|
Form
of Company Support Agreement by and among BCTG Acquisition Corp., certain stockholders of Tango Therapeutics, Inc. and Tango Therapeutics,
Inc. (included as Exhibit A to exhibit 2.1)
|
10.3
|
|
Form
of Parent Support Agreement (included as Exhibit B to exhibit 2.1)
|
10.4
|
|
Form
of Amended and Restated Registration Rights Agreement (included as Exhibit G to exhibit 2.1)
|
10.5
|
|
Form
of Stockholder Lock-Up Agreement (included as Exhibit D to exhibit 2.1)
|
99.1**
|
|
Press
Release dated April 14, 2021
|
99.2**
|
|
Investor
Presentation dated April 14, 2021
|
*
|
Schedules and exhibits
have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the
omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.
|
**
|
Furnished but not filed.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated: April 14, 2021
|
|
|
|
BCTG ACQUISITION CORP.
|
|
|
|
By:
|
/s/
Aaron I. Davis
|
|
Name:
|
Aaron I. Davis
|
|
Title:
|
Chief Executive Officer
|
|
8
Grafico Azioni BCTG Acquisition (NASDAQ:BCTG)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni BCTG Acquisition (NASDAQ:BCTG)
Storico
Da Mag 2023 a Mag 2024